CEA Blood Test

How Does It Work?

Documenting medical information accurately and comprehensively is fundamental to providing quality healthcare. Here's a step-by-step guide on how to effectively use this Printable CEA Blood Test:

Step 1: Gather Patient Information

Begin by collecting essential patient information, including their full name, date of birth, gender, and medical record number (MRN). Ensure the accuracy of this data.

Step 2: Record CEA Blood Test Results

Enter the results of the CEA Blood Test into the template. Include the numeric CEA level, its interpretation (elevated, average, etc.), the reference range, and the units used for measurement (e.g., ng/mL).

Step 3: Document Clinical Context

Provide relevant clinical context by noting the patient's primary diagnosis (e.g., colorectal cancer), a brief treatment history (if applicable), and the reason for conducting the CEA Blood Test.

Step 4: Physician's Recommendations

Detail the physician's recommendations based on the CEA test results. This could include the next steps in the patient's care, such as scheduling follow-up appointments or ordering additional tests or treatments.

Step 5: Sign and Date

Ensure the document is signed and dated by the healthcare provider responsible for reviewing the CEA Blood Test results and making recommendations. This signature adds accountability and authenticity to the record.

When Would You Use This Test?

The CEA Blood Test is used in various medical scenarios to detect, monitor, and manage cancer. It serves as a diagnostic tool to aid in identifying cancer, particularly in gastrointestinal or related malignancies, such as colorectal, lung, breast, and pancreatic cancer.

It helps assess the effectiveness of cancer treatments and monitor post-treatment patients for cancer recurrence. These tests also evaluate treatment response and may be used in select high-risk individuals as part of cancer screening programs.

CEA tests are also utilized in some clinical scenarios to assess treatment response and guide therapeutic decisions. For instance, in cases where a patient's CEA levels remain elevated despite treatment, healthcare providers may consider alternative therapies or further diagnostic tests to tailor the treatment plan more effectively.

It's important to note that while CEA tests provide valuable insights, they are typically interpreted alongside other clinical data and trials to make informed medical decisions. The precise application of the CEA blood test depends on an individual's medical history, symptoms, and the judgment of their healthcare provider.

What Do the Results Mean?

Here's what different CEA blood test results may generally indicate:

• Low CEA Level (Before Cancer Treatment): A low CEA level may suggest that the tumor is relatively small and has not spread extensively. However, certain cancers may not produce significant amounts of CEA, particularly certain types. In such cases, healthcare providers may rely on additional tests, including this free CEA Blood Test, to assess the extent of cancer involvement.
• High CEA Level (Before Cancer Treatment): An elevated CEA level may indicate a larger tumor or the potential spread of cancer to other body areas. However, further tests are typically necessary to confirm the severity and extent of cancer.
• Monitoring During or After Treatment: When CEA tests are used to monitor cancer during or after treatment, your healthcare provider will compare current results with past ones:
• Decreasing CEA Levels: A consistent decrease in CEA levels over time is generally a positive sign, suggesting that the treatment effectively controls or reduces the cancer.
• Increasing or Persistently High CEA Levels: Conversely, elevated levels may indicate that the treatment is not having the desired effect. For instance, in the context of colorectal cancer surgery, this may suggest that the entire tumor wasn't successfully removed or that the cancer is regrowing.
• Decreasing CEA Followed by Increases: This pattern may suggest that the cancer has returned after an initial positive response to treatment. It's crucial to investigate further in such cases.

Research & Evidence

Carcinoembryonic antigen (CEA) is a serum biomarker initially discovered in colon cancer cells by Freedman and Gold. Over time, research has revealed its presence in various other epithelial cells across the body, including those in the stomach, tongue, esophagus, cervix, and prostate.

CEA is a non-specific marker, and its levels can become elevated in several malignancies, such as colorectal cancer, medullary thyroid cancer, breast cancer, mucinous ovarian cancer, and more. 

As our understanding of CEA and its association with different cancers has deepened, its clinical significance and utility in cancer diagnosis and management have evolved, making it an increasingly valuable tool in modern oncology.

Reference

• Kankanala VL, Mukkamalla SKR. Carcinoembryonic Antigen. [Updated 2022 Jan 26; cited 2022 Dec 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan